Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial

Psychiatry and Clinical Neurosciences
J IshigookaS Miura

Abstract

This randomized double-blind trial was conducted to test the efficacy and safety of olanzapine in Japanese patients with schizophrenia. Importantly, this study also represents the first large clinical trial of olanzapine conducted in an Asian population. Patients (n = 182) were randomly assigned to treatment with olanzapine or haloperidol over a period of 8 weeks. The primary analyses included: (i) a test of non-inferiority of olanzapine compared with haloperidol in efficacy using the Final Global Improvement Rating (FGIR); and (ii) comparison between the treatment groups in extrapyramidal symptom severity using the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS). Olanzapine was comparable to haloperidol in efficacy in treating positive symptoms and significantly superior in treating negative symptoms. Extrapyramidal symptom severity was significantly improved for olanzapine-treated patients versus haloperidol-treated patients. Olanzapine was shown to be more effective and better tolerated than haloperidol in the treatment of Japanese patients suffering from chronic schizophrenia.

References

Dec 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Jong-Hoon KimYong Sik Kim
Jul 10, 2003·General Hospital Psychiatry·Naoshi HorikawaKiyoshi Takamatsu
Sep 3, 2003·Psychiatry and Clinical Neurosciences·Nan Ying ChiuJiunn-Ren Lee
May 11, 2006·The Australian and New Zealand Journal of Psychiatry·Chul LeePhil Lee
Sep 22, 2005·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Peter FalkaiWFSBP Task Force on Treatment Guidelines for Schizophrenia
Jul 18, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Zheng LuQiuqing Ang
Apr 10, 2003·The Psychiatric Clinics of North America·Robin Emsley, Piet Oosthuizen
Jul 28, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alkomiet HasanWorld Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia
May 4, 2005·The International Journal of Social Psychiatry·Bettina Hübner-LiebermannC Cording
Oct 5, 2012·The International Journal of Social Psychiatry·Kumi MoriwakiKazumasa Iwai
Apr 23, 2005·The Cochrane Database of Systematic Reviews·L DugganS Indran
Jan 24, 2007·Journal of Psychiatric Practice·Peter J Weiden
Jun 11, 2014·The Cochrane Database of Systematic Reviews·Jataveda MahapatraClive E Adams
Jun 17, 2011·The Cochrane Database of Systematic Reviews·John BolaHaluk Soydan
Dec 19, 2001·International Journal of Geriatric Psychiatry·J S KennedyA Breier

Citations

May 1, 1991·Clinical Pharmacokinetics·A J Wood, H H Zhou
Jan 1, 1991·Schizophrenia Bulletin·N C Andreasen
Sep 1, 1981·The American Journal of Psychiatry·R L Binder, R Levy
Feb 1, 1995·Journal of Clinical Pharmacology·Y W LamC M Davis
Feb 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C M BeasleyS H Hamilton
Mar 1, 1996·Psychopharmacology·C M BeasleyS H Hamilton
Feb 1, 1997·Progress in Neuro-psychopharmacology & Biological Psychiatry·H Y LaneW H Chang
May 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·C M BeasleyJ N Beuzen
Nov 26, 1998·The British Journal of Psychiatry : the Journal of Mental Science·P V TranC M Beasley
Sep 4, 1999·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Dennis A RevickiC M Beasley
Jul 10, 2001·Psychiatry and Clinical Neurosciences·J IshigookaOlanzapine Early-Phase II Study Group

Related Concepts

Patient Non-Compliance
Antipsychotic Effect
Schizophrenia
Severity of Illness Index
Pseudoakathisia
Haldol
Benzodiazepines
Incisors, Fused Mandibular
Zyprexa
Double-Blind Method

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.